DE60122685D1 - Induziertes genexpressionssystem basierend auf ecdysonrezeptoren - Google Patents

Induziertes genexpressionssystem basierend auf ecdysonrezeptoren

Info

Publication number
DE60122685D1
DE60122685D1 DE60122685T DE60122685T DE60122685D1 DE 60122685 D1 DE60122685 D1 DE 60122685D1 DE 60122685 T DE60122685 T DE 60122685T DE 60122685 T DE60122685 T DE 60122685T DE 60122685 D1 DE60122685 D1 DE 60122685D1
Authority
DE
Germany
Prior art keywords
ecdyson
receptors
gene expression
system based
expression system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122685T
Other languages
English (en)
Other versions
DE60122685T2 (de
Inventor
Reddy Palli
Marianna Zinovjevna Kapitskaya
Ervin Cress
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precigen Inc
Original Assignee
Rheogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rheogene Inc filed Critical Rheogene Inc
Application granted granted Critical
Publication of DE60122685D1 publication Critical patent/DE60122685D1/de
Publication of DE60122685T2 publication Critical patent/DE60122685T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60122685T 2000-03-22 2001-03-21 Induziertes genexpressionssystem basierend auf ecdysonrezeptoren Expired - Lifetime DE60122685T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19135500P 2000-03-22 2000-03-22
US191355P 2000-03-22
US26979901P 2001-02-20 2001-02-20
US269799P 2001-02-20
PCT/US2001/009050 WO2001070816A2 (en) 2000-03-22 2001-03-21 Ecdysone receptor-based inducible gene expression system

Publications (2)

Publication Number Publication Date
DE60122685D1 true DE60122685D1 (de) 2006-10-12
DE60122685T2 DE60122685T2 (de) 2007-08-23

Family

ID=26886975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122685T Expired - Lifetime DE60122685T2 (de) 2000-03-22 2001-03-21 Induziertes genexpressionssystem basierend auf ecdysonrezeptoren

Country Status (11)

Country Link
US (1) US7091038B2 (de)
EP (1) EP1266015B1 (de)
JP (1) JP5031967B2 (de)
CN (1) CN1304578C (de)
AR (1) AR028276A1 (de)
AT (1) ATE338135T1 (de)
AU (2) AU2001249315A1 (de)
CA (1) CA2404253C (de)
DE (1) DE60122685T2 (de)
MX (1) MXPA02009157A (de)
WO (1) WO2001070816A2 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033600A1 (en) 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
EP1356066A2 (de) * 2000-10-24 2003-10-29 Syngenta Participations AG Kontrolle der pflanzengenexpression
WO2002066615A2 (en) 2001-02-20 2002-08-29 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
MXPA03007492A (es) * 2001-02-20 2004-10-15 Rheogene Holdings Inc Receptores de retinoide x quimerico y su uso en un sistema de expresion de gen inducible basado en receptor de ecdisona novedoso.
EP1373470B1 (de) 2001-02-20 2013-04-24 Intrexon Corporation Neue substitutionsmutantenrezeptoren und ihre verwendung in einem induzierbaren genexpressionssystem auf basis eines nukleären rezeptors
EP1456346B1 (de) * 2001-02-20 2012-02-15 Intrexon Corporation Neues induzierbares genexpressionssystem auf ecdysonrezeptor/invertebraten-retinoid-x-rezeptor-basis
WO2003030125A1 (de) * 2001-09-25 2003-04-10 Werner Keber Verfahren und einrichtung zum verhindern einer unzulässiggen flugannäherung von flugzeugen an zu schützende bodenobjekte
US7563879B2 (en) 2001-09-26 2009-07-21 Intrexon Corporation Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
US7919269B2 (en) 2001-09-26 2011-04-05 Intrexon Corporation Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
CA2475235C (en) * 2002-02-05 2013-04-30 Geymonat S.P.A. Production process of recombinant placental growth factor
US9154906B2 (en) 2002-03-28 2015-10-06 Telecommunication Systems, Inc. Area watcher for wireless network
US7375093B2 (en) * 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
WO2004070028A1 (ja) * 2003-02-07 2004-08-19 Kumiai Chemical Industry Co., Ltd. 脱皮ホルモン受容体及び当該受容体に対するリガンドのスクリーニング方法
AU2011202682B2 (en) * 2003-02-10 2013-11-28 Intrexon Corporation Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7304161B2 (en) * 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en) 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7790377B2 (en) 2003-08-29 2010-09-07 The University Of North Carolina At Greensboro Compounds that act to modulate insect growth and methods and systems for identifying such compounds
US8637237B2 (en) 2003-08-29 2014-01-28 The University Of North Carolina At Greensboro Methods, compositions, and systems for the identification of species-specific or developmental stage-specific insecticides
US20050164210A1 (en) * 2004-01-23 2005-07-28 Vivek Mittal Regulated polymerase III expression systems and related methods
US7935510B2 (en) * 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
JP4517347B2 (ja) * 2004-07-02 2010-08-04 国立大学法人北海道大学 植物を用いたエストロゲン様物質の検出方法
WO2006017813A2 (en) * 2004-08-04 2006-02-16 University Of Utah Research Foundation Methods and compositions for detecting steroids
US8115059B1 (en) 2005-07-22 2012-02-14 University Of Kentucky Research Foundation Gene expression modulation system for use in plants and method for modulating gene expression in plants
JP2009505955A (ja) 2005-07-22 2009-02-12 アムゲン インコーポレイティッド アニリンスルホンアミド誘導体およびそれらの使用
PL2043662T3 (pl) 2006-07-26 2016-03-31 Intrexon Corp Sposoby i kompozycje do leczenia choroby
CN101016518B (zh) * 2006-09-12 2010-07-28 南方医科大学 一种生物杀虫剂筛选模型及其制备方法和应用
US8455628B2 (en) * 2007-05-02 2013-06-04 Intrexon Corporation PP1 ligands
MX363066B (es) 2007-05-29 2019-03-07 Intrexon Corp Ligandos quirales de diacilhidrazina para modular la expresion de genes exogenos por medio de un complejo receptor de ecdisona.
CA2698212A1 (en) 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
AU2008302504B2 (en) * 2007-09-17 2014-08-14 Agrofresh Inc. Compositions and methods for the modification of physiological responses in plants
AU2008307643B9 (en) 2007-09-28 2014-04-17 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
HUE024479T2 (en) 2007-10-08 2016-01-28 Intrexon Corp Genetically altered dendritic cells and uses for cancer treatment
CA2718494C (en) * 2008-03-14 2016-05-17 Intrexon Corporation Steroidal ligands and their use in gene switch modulation
MX340972B (es) 2008-10-08 2016-08-02 Intrexon Corp Celulas manipuladas por ingenieria que expresan multiples inmunomoduladores, y uso de las mismas.
MX2011009239A (es) 2009-03-05 2011-09-15 Rohm & Haas Control de rotacion apuntada de proteina de ruta de señalizacion de hormona de etileno clave para modular la sensibilidad a etileno en plantas.
MX362513B (es) 2010-03-23 2019-01-22 Intrexon Corp Vectores que expresan de manera condicional proteinas terapeuticas, celulas hospedadoras que comprenden vectores, y usos de los mismos.
EP2619313B1 (de) 2010-09-26 2021-11-10 Da Yu Enterprises, L.L.C. Verfahren zur herstellung rekombinanter makromoleküle
JP6189754B2 (ja) 2011-03-04 2017-08-30 イントレキソン コーポレーション タンパク質を条件的に発現するベクター
EP2699688A1 (de) 2011-04-20 2014-02-26 The Trustees Of The University Of Pennsylvania Dosierpläne und zusammensetzungen zur aav-vermittelten passiven immunisierung von luftbürtigen krankheitserregern
WO2014144380A1 (en) 2013-03-15 2014-09-18 Intrexon Corporation Boron-containing diacylhydrazines
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CA2918452A1 (en) 2013-07-15 2015-01-22 Donald Danforth Plant Science Center Enhanced oil production and stress tolerance in plants
CN103555727B (zh) * 2013-10-14 2015-06-10 中国水产科学研究院淡水渔业研究中心 一种中华绒螯蟹性早熟个体活体分子检测方法
SG11201701944WA (en) 2014-09-17 2017-04-27 Intrexon Corp Boron-containing diacylhydrazine compounds
EP3278110A4 (de) * 2015-03-30 2018-08-29 Intrexon Corporation Ligandeninduzierbares polypeptidkopplersystem
WO2016200543A2 (en) 2015-05-13 2016-12-15 The Trustees Of The University Of Pennsylvania Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
AU2016334401A1 (en) 2015-10-10 2018-04-26 Intrexon Corporation Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
CA3004742A1 (en) 2015-11-11 2017-05-18 Intrexon Corporation Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
PE20181535A1 (es) 2015-12-16 2018-09-26 Gritstone Oncology Inc Identificacion, fabricacion y uso de neoantigeno
CA3025667A1 (en) 2016-06-08 2017-12-14 Intrexon Corporation Cd33 specific chimeric antigen receptors
UY37343A (es) 2016-07-25 2018-02-28 Intrexon Corp Control del fenotipo en plantas
MX2019005235A (es) 2016-11-09 2019-12-05 Intrexon Corp Constructos de expresion de frataxina.
CN106589125B (zh) * 2016-12-23 2020-04-14 江苏省农业科学院 抗绿盲蝽蜕皮激素受体蛋白的单克隆抗体及其用途
WO2018132494A1 (en) 2017-01-10 2018-07-19 Intrexon Corporation Modulating expression of polypeptides via new gene switch expression systems
SG11201907611WA (en) 2017-02-28 2019-09-27 Univ Pennsylvania Influenza vaccines based on aav vectors
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
HRP20240257T1 (hr) 2017-02-28 2024-05-24 The Trustees Of The University Of Pennsylvania Adeno-povezani virusni (aav) clade f vektor i njegova uporaba
CN110997920A (zh) 2017-06-07 2020-04-10 英特拉克森公司 新型细胞标签的表达
JP7227237B2 (ja) 2017-10-10 2023-02-21 グリットストーン バイオ インコーポレイテッド ホットスポットを利用した新生抗原の特定
AU2018373154A1 (en) 2017-11-22 2020-07-02 Gritstone Bio, Inc. Reducing junction epitope presentation for neoantigens
EP3762010A4 (de) 2018-03-06 2022-04-06 Precigen, Inc. Hepatitis-b-impfstoffe und verwendungen davon
CN108913732B (zh) * 2018-07-31 2022-02-08 华东理工大学 一种莫纳可林j异源生产的方法及应用
CN109810993B (zh) * 2019-03-25 2022-05-31 临沂大学 一种蝗虫β-D-葡萄糖苷水解酶基因及其应用
WO2020206056A1 (en) 2019-04-04 2020-10-08 Greenvenus Llc Peptides and methods of plant protection
CN110592095A (zh) * 2019-09-26 2019-12-20 浙江海洋大学 曼氏无针乌贼维甲酸x受体基因的克隆和表达
EP4061950A2 (de) * 2019-11-19 2022-09-28 Teknologian Tutkimuskeskus VTT OY Nicht-virale transkriptionsaktivierungsdomänen und verfahren und verwendungen davon
TW202237850A (zh) 2020-12-01 2022-10-01 賓州大學委員會 具有組織特異性靶向基序的新穎構成物及含有其之組成物
AR125406A1 (es) 2021-04-23 2023-07-12 Univ Pennsylvania Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen
TW202325845A (zh) 2021-10-02 2023-07-01 賓州大學委員會 新穎aav衣殼及含其之組成物
WO2023147304A1 (en) 2022-01-25 2023-08-03 The Trustees Of The University Of Pennsylvania Aav capsids for improved heart transduction and detargeting of liver
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
WO2024130067A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
CA2075192A1 (en) 1990-03-22 1991-09-23 Anthony E. Oro Insect retinoid receptor compositions and methods
AU703124B2 (en) * 1995-03-03 1999-03-18 Syngenta Participations Ag Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
CA2200423C (en) * 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
IL126418A0 (en) * 1996-04-05 1999-05-09 Salk Inst For Biological Studi Hormone-mediated methods for modulating expression of exogenous genes and pharmaceutical compositions for modulating the same
US5919667A (en) * 1996-06-20 1999-07-06 The Salk Institute For Biological Studies Modular assembly retroviral vectors and uses thereof
US6300488B1 (en) 1997-07-10 2001-10-09 The Salk Institute For Biological Studies Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
EP0998560A1 (de) * 1997-07-10 2000-05-10 The Salk Institute For Biological Studies Modifizierte lepidoptera-rezeptoren und hybride, multifunktionelle proteine zur regulation der expression von transgenen
CA2300376A1 (en) * 1997-08-26 1999-03-04 Ariad Gene Therapeutics, Inc. Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
US6333318B1 (en) * 1998-05-14 2001-12-25 The Salk Institute For Biological Studies Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
US6258603B1 (en) * 1998-06-17 2001-07-10 Rohm And Haas Company Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

Also Published As

Publication number Publication date
EP1266015B1 (de) 2006-08-30
CA2404253A1 (en) 2001-09-27
AU2007200882A1 (en) 2007-03-22
CA2404253C (en) 2014-05-13
CN1422334A (zh) 2003-06-04
US7091038B2 (en) 2006-08-15
AU2007200882B2 (en) 2011-05-19
WO2001070816A3 (en) 2002-08-29
US20020119521A1 (en) 2002-08-29
DE60122685T2 (de) 2007-08-23
MXPA02009157A (es) 2004-04-05
AU2001249315A1 (en) 2001-10-03
JP2003527852A (ja) 2003-09-24
JP5031967B2 (ja) 2012-09-26
WO2001070816A2 (en) 2001-09-27
CN1304578C (zh) 2007-03-14
ATE338135T1 (de) 2006-09-15
AR028276A1 (es) 2003-04-30
EP1266015A2 (de) 2002-12-18

Similar Documents

Publication Publication Date Title
DE60122685D1 (de) Induziertes genexpressionssystem basierend auf ecdysonrezeptoren
DE60329919D1 (de) En auf tensidbasis
DE60044784D1 (de) Auf software basierter stempelgeber
DE60109979D1 (de) Navigationssystem
DE60123299D1 (de) Navigationssystem
DE50212862D1 (de) Emulsionen auf basis spezieller emulgatoren
DE69905638T2 (de) Fussgänger-Aufprallsensorsystem
DE60125769D1 (de) Verbessertes elektroentionisierungssystem
DE60028515D1 (de) Navigationssystem
NO330957B1 (no) Navigering
DE50002814D1 (de) Ansaugsystem
DE60205144D1 (de) Kraftstoffsystemteil
DE60132946D1 (de) Navigationssystem
DE50212435D1 (de) Emulsionen auf basis spezieller emulgatoren
DE50114578D1 (de) Navigationssystem
FI19992495A (fi) Lippujärjestelmä
DE60134818D1 (de) Informationbereitstellungssystem
DE60127700D1 (de) Strick-entwurfsystem
DE10196521T1 (de) Brennstoff-System
DE69930599D1 (de) Kraftstoffsystem
DE60036888D1 (de) Navigationssystem
DE60043435D1 (de) Navigationssystem
DE60028416D1 (de) Duplexdrucksystem
DE50104318D1 (de) Lernsystem
DE60039405D1 (de) Navigationssystem

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTREXON CORP., BLACKBURG, VA., US